The report provides an analysis of non-hodgkin lymphoma partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors non-hodgkin lymphoma technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
http://bit.ly/1Dl4eao
No comments:
Post a Comment